ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.

Abstract

ERG is immunoexpressed in vascular endothelial tumors, blastic extramedullary myeloid tumors, and tumors with ERG-involved translocation, such as prostate carcinoma or Ewing sarcoma. Recently, ERG immunoexpression was reported in an epithelioid sarcoma, which is a SMARCB1/INI1-deficient tumor, although epithelioid sarcoma is not associated with chromosomal… (More)
DOI: 10.1016/j.humpath.2014.10.010

Topics

4 Figures and Tables

Statistics

050201520162017
Citations per Year

Citation Velocity: 15

Averaging 15 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Kohashi2015ERGAS, title={ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.}, author={Kenichi Kohashi and Yuichi Yamada and Yuka Hotokebuchi and Hidetaka Yamamoto and Tomoaki Taguchi and Yukihide Iwamoto and Yoshinao Oda}, journal={Human pathology}, year={2015}, volume={46 2}, pages={225-30} }